Precancerous  ||| S:0 E:13 ||| JJ
conditions  ||| S:13 E:24 ||| NNS
in  ||| S:24 E:27 ||| IN
the  ||| S:27 E:31 ||| DT
ENT  ||| S:31 E:35 ||| NNP
area  ||| S:35 E:40 ||| NN
An  ||| S:40 E:43 ||| DT
important  ||| S:43 E:53 ||| JJ
part  ||| S:53 E:58 ||| NN
of  ||| S:58 E:61 ||| IN
tumor  ||| S:61 E:67 ||| NN
prevention  ||| S:67 E:78 ||| NN
is  ||| S:78 E:81 ||| VBZ
early  ||| S:81 E:87 ||| JJ
detection ||| S:87 E:96 ||| NN
,  ||| S:96 E:98 ||| ,
dia-gnosis ||| S:98 E:108 ||| NNP
,  ||| S:108 E:110 ||| ,
treatment  ||| S:110 E:120 ||| NN
and  ||| S:120 E:124 ||| CC
screening  ||| S:124 E:134 ||| NN
of  ||| S:134 E:137 ||| IN
precancerous  ||| S:137 E:150 ||| JJ
conditions ||| S:150 E:160 ||| NNS
.  ||| S:160 E:162 ||| .
Correct  ||| S:162 E:170 ||| JJ
detection  ||| S:170 E:180 ||| NN
and  ||| S:180 E:184 ||| CC
screening  ||| S:184 E:194 ||| NN
of  ||| S:194 E:197 ||| IN
premalignant  ||| S:197 E:210 ||| JJ
lesions  ||| S:210 E:218 ||| NN
leads  ||| S:218 E:224 ||| VBZ
to  ||| S:224 E:227 ||| TO
early  ||| S:227 E:233 ||| JJ
dia-gnosis  ||| S:233 E:244 ||| NN
of  ||| S:244 E:247 ||| IN
a  ||| S:247 E:249 ||| DT
malignant  ||| S:249 E:259 ||| JJ
process  ||| S:259 E:267 ||| NN
which  ||| S:267 E:273 ||| WDT
provides  ||| S:273 E:282 ||| VBZ
a  ||| S:282 E:284 ||| DT
better  ||| S:284 E:291 ||| JJR
chance  ||| S:291 E:298 ||| NN
to  ||| S:298 E:301 ||| TO
completely  ||| S:301 E:312 ||| RB
cure  ||| S:312 E:317 ||| VB
the  ||| S:317 E:321 ||| DT
patient  ||| S:321 E:329 ||| NN
and  ||| S:329 E:333 ||| CC
also  ||| S:333 E:338 ||| RB
predicts  ||| S:338 E:347 ||| VBZ
better  ||| S:347 E:354 ||| JJR
quality  ||| S:354 E:362 ||| NN
of  ||| S:362 E:365 ||| IN
life ||| S:365 E:369 ||| NN
.  ||| S:369 E:371 ||| .
Precancerous  ||| S:371 E:384 ||| JJ
conditions  ||| S:384 E:395 ||| NNS
look  ||| S:395 E:400 ||| VBP
like  ||| S:400 E:405 ||| IN
whitish ||| S:405 E:412 ||| NN
,  ||| S:412 E:414 ||| ,
red  ||| S:414 E:418 ||| JJ
or  ||| S:418 E:421 ||| CC
mixed  ||| S:421 E:427 ||| JJ
mucose  ||| S:427 E:434 ||| JJ
lesions  ||| S:434 E:442 ||| NNS
( ||| S:442 E:443 ||| -LRB-
leukoplakia ||| S:443 E:454 ||| UH
,  ||| S:454 E:456 ||| ,
erytroplakia ||| S:456 E:468 ||| NN
,  ||| S:468 E:470 ||| ,
erytroleukoplakia ||| S:470 E:487 ||| CD
)  ||| S:487 E:489 ||| -RRB-
which  ||| S:489 E:495 ||| WDT
are  ||| S:495 E:499 ||| VBP
visible  ||| S:499 E:507 ||| JJ
during  ||| S:507 E:514 ||| IN
clinical  ||| S:514 E:523 ||| JJ
examination ||| S:523 E:534 ||| NN
.  ||| S:534 E:536 ||| .
Nevertheless ||| S:536 E:548 ||| RB
,  ||| S:548 E:550 ||| ,
these  ||| S:550 E:556 ||| DT
mucose  ||| S:556 E:563 ||| JJ
changes  ||| S:563 E:571 ||| NNS
are  ||| S:571 E:575 ||| VBP
not  ||| S:575 E:579 ||| RB
absolutely  ||| S:579 E:590 ||| RB
conclusive ||| S:590 E:600 ||| VBN
.  ||| S:600 E:602 ||| .
Therefore ||| S:602 E:611 ||| RB
,  ||| S:611 E:613 ||| ,
histological  ||| S:613 E:626 ||| JJ
testing  ||| S:626 E:634 ||| NN
is  ||| S:634 E:637 ||| VBZ
necessary  ||| S:637 E:647 ||| JJ
for  ||| S:647 E:651 ||| IN
dia-gnosis  ||| S:651 E:662 ||| JJ
and  ||| S:662 E:666 ||| CC
determination  ||| S:666 E:680 ||| NN
of  ||| S:680 E:683 ||| IN
bio-logical  ||| S:683 E:695 ||| JJ
potencial  ||| S:695 E:705 ||| NN
of  ||| S:705 E:708 ||| IN
precancerous  ||| S:708 E:721 ||| JJ
lesions ||| S:721 E:728 ||| NNS
.  ||| S:728 E:730 ||| .
Precancerous  ||| S:730 E:743 ||| JJ
lesions  ||| S:743 E:751 ||| NNS
as  ||| S:751 E:754 ||| IN
a  ||| S:754 E:756 ||| DT
term  ||| S:756 E:761 ||| NN
of  ||| S:761 E:764 ||| IN
histological  ||| S:764 E:777 ||| JJ
terminology  ||| S:777 E:789 ||| NN
means  ||| S:789 E:795 ||| VBZ
dysplasia ||| S:795 E:804 ||| VBN
.  ||| S:804 E:806 ||| .
The  ||| S:806 E:810 ||| DT
risk  ||| S:810 E:815 ||| NN
of  ||| S:815 E:818 ||| IN
progression  ||| S:818 E:830 ||| NN
of  ||| S:830 E:833 ||| IN
dysplasia  ||| S:833 E:843 ||| NN
into  ||| S:843 E:848 ||| IN
a  ||| S:848 E:850 ||| DT
carcinoma  ||| S:850 E:860 ||| NN
depends  ||| S:860 E:868 ||| VBZ
on  ||| S:868 E:871 ||| IN
a  ||| S:871 E:873 ||| DT
grade  ||| S:873 E:879 ||| NN
of  ||| S:879 E:882 ||| IN
dysplasia ||| S:882 E:891 ||| NN
.  ||| S:891 E:893 ||| .
The  ||| S:893 E:897 ||| DT
conservative  ||| S:897 E:910 ||| JJ
or  ||| S:910 E:913 ||| CC
surgical  ||| S:913 E:922 ||| JJ
treatment  ||| S:922 E:932 ||| NN
is  ||| S:932 E:935 ||| VBZ
chosen  ||| S:935 E:942 ||| VBN
according  ||| S:942 E:952 ||| VBG
to  ||| S:952 E:955 ||| TO
localisation  ||| S:955 E:968 ||| VB
and  ||| S:968 E:972 ||| CC
grade  ||| S:972 E:978 ||| NN
of  ||| S:978 E:981 ||| IN
dysplasia ||| S:981 E:990 ||| NN
.  ||| S:990 E:992 ||| .
